KEVIN C OBOYLE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN C OBOYLE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN C OBOYLE. KEVIN C OBOYLE is CFO and Executive VP in NUVASIVE INC ($NUVA) and VP, Finance and CFO in NUVASIVE INC ($NUVA) and Director in Zeltiq Aesthetics Inc ($ZLTQ) and Director in NEVRO CORP ($NVRO) and Director in GenMark Diagnostics, Inc. ($GNMK) and Director in Wright Medical Group N.V. ($TRNX) and Director in Sientra, Inc. ($SIEN).
Latest Insider Trading Transactions of KEVIN C OBOYLE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GNMK, NVRO, NUVA, SIEN, TRNX, ZLTQ
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2021 | SIEN | Sientra, Inc. | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 16,870 | 0 | 117,672 | 100.8 K to 117.7 K (+16.74 %) |
| May 26 2021 | NVRO | NEVRO CORP | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 1,167 | 0 | 10,918 | 9.8 K to 10.9 K (+11.97 %) |
| Apr 22 2021 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Option Exercise | D | 4.38 | 13,426 | 58,806 | 0 | |
| Apr 22 2021 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Sell | U | 24.05 | 131,678 | 3,166,856 | 0 | 131.7 K to 0 (-100.00 %) |
| Feb 19 2021 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 10,130 | 0 | 131,678 | 121.5 K to 131.7 K (+8.33 %) |
| Nov 13 2020 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | D | 25.20 | 7,800 | 196,560 | 0 | |
| Nov 13 2020 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | D | 18.04 | 6,448 | 116,322 | 0 | |
| Nov 13 2020 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | D | 19.45 | 7,538 | 146,614 | 0 | |
| Nov 13 2020 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | D | 21.66 | 6,034 | 130,696 | 0 | |
| Nov 13 2020 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | D | 20.62 | 11,018 | 227,191 | 0 | |
| Nov 13 2020 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | D | 21.24 | 11,765 | 249,889 | 0 | |
| Nov 13 2020 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | D | 27.86 | 10,275 | 286,262 | 0 | |
| Nov 13 2020 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | D | 24.49 | 9,907 | 242,622 | 0 | |
| Nov 13 2020 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | D | 27.84 | 11,691 | 325,477 | 0 | |
| Nov 13 2020 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Sell | U | 30.75 | 16,306 | 501,410 | 0 | 16.3 K to 0 (-100.00 %) |
| Jun 09 2020 | SIEN | Sientra, Inc. | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 27,717 | 0 | 100,802 | 73.1 K to 100.8 K (+37.92 %) |
| Jun 02 2020 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 17,998 | 0 | 121,548 | 103.6 K to 121.5 K (+17.38 %) |
| May 26 2020 | NVRO | NEVRO CORP | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 1,376 | 0 | 9,751 | 8.4 K to 9.8 K (+16.43 %) |
| Mar 09 2020 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Buy | P | 4.53 | 10,800 | 48,924 | 103,550 | 92.8 K to 103.6 K (+11.64 %) |
| Feb 27 2020 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 3,973 | 0 | 92,750 | 88.8 K to 92.8 K (+4.48 %) |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Option Exercise | M | 6.00 | 18,050 | 108,300 | 0 | |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Option Exercise | M | 6.00 | 25,000 | 150,000 | 0 | |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Payment of Exercise | F | 6.42 | 16,870 | 108,305 | 88,777 | 105.6 K to 88.8 K (-15.97 %) |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Payment of Exercise | F | 6.42 | 23,365 | 150,003 | 105,647 | 129 K to 105.6 K (-18.11 %) |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Buy | M | 6.00 | 18,050 | 108,300 | 129,012 | 111 K to 129 K (+16.27 %) |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Buy | M | 6.00 | 25,000 | 150,000 | 110,962 | 86 K to 111 K (+29.08 %) |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Sell | S | 6.51 | 16,150 | 105,137 | 85,962 | 102.1 K to 86 K (-15.82 %) |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Sell | S | 6.51 | 2,200 | 14,322 | 102,112 | 104.3 K to 102.1 K (-2.11 %) |
| Jul 30 2019 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | A | 27.84 | 11,691 | 325,477 | 11,691 | |
| Jul 30 2019 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 3,916 | 0 | 16,306 | 12.4 K to 16.3 K (+31.61 %) |
| Jun 18 2019 | SIEN | Sientra, Inc. | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 19,320 | 0 | 73,085 | 53.8 K to 73.1 K (+35.93 %) |
| Jun 11 2019 | SIEN | Sientra, Inc. | OBOYLE KEVIN C | Director | Buy | P | 5.75 | 8,696 | 50,002 | 53,765 | 45.1 K to 53.8 K (+19.29 %) |
| Jun 07 2019 | NVRO | NEVRO CORP | OBOYLE KEVIN C | Director | Buy | P | 60.00 | 1,675 | 100,500 | 8,375 | 6.7 K to 8.4 K (+25.00 %) |
| Jun 04 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 19,851 | 0 | 104,312 | 84.5 K to 104.3 K (+23.50 %) |
| May 22 2019 | NVRO | NEVRO CORP | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 6,049 | 0 | 6,700 | 651 to 6.7 K (+929.19 %) |
| Mar 21 2019 | NVRO | NEVRO CORP | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 651 | 0 | 651 | 0 to 651 |
| Mar 05 2019 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Sell | S | 32.00 | 6,417 | 205,344 | 12,390 | 18.8 K to 12.4 K (-34.12 %) |
| Feb 20 2019 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Sell | S | 32.01 | 3,583 | 114,680 | 18,807 | 22.4 K to 18.8 K (-16.00 %) |
| Feb 01 2019 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | M | 22.50 | 30,816 | 693,360 | 0 | |
| Feb 01 2019 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | M | 22.50 | 1,907 | 42,908 | 30,816 | |
| Feb 01 2019 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Sell | S | 30.07 | 30,816 | 926,566 | 22,390 | 53.2 K to 22.4 K (-57.92 %) |
| Feb 01 2019 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Buy | M | 22.50 | 30,816 | 693,360 | 53,206 | 22.4 K to 53.2 K (+137.63 %) |
| Feb 01 2019 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Sell | S | 30.00 | 1,907 | 57,210 | 22,390 | 24.3 K to 22.4 K (-7.85 %) |
| Feb 01 2019 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Buy | M | 22.50 | 1,907 | 42,908 | 24,297 | 22.4 K to 24.3 K (+8.52 %) |
| Jul 26 2018 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | A | 24.49 | 9,907 | 242,622 | 9,907 | |
| Jul 26 2018 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Payment of Exercise | F | 24.83 | 626 | 15,544 | 22,389 | 23 K to 22.4 K (-2.72 %) |
| Jul 26 2018 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 3,804 | 0 | 23,015 | 19.2 K to 23 K (+19.80 %) |
| Jun 07 2018 | SIEN | Sientra, Inc. | OBOYLE KEVIN C | Director | Grant | A | 20.44 | 6,116 | 125,011 | 45,069 | 39 K to 45.1 K (+15.70 %) |
| May 29 2018 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 18,866 | 0 | 84,461 | 65.6 K to 84.5 K (+28.76 %) |
| May 09 2018 | SIEN | Sientra, Inc. | OBOYLE KEVIN C | Director | Buy | P | 13.50 | 7,407 | 99,995 | 38,953 | 31.5 K to 39 K (+23.48 %) |
| Jul 26 2017 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | A | 27.86 | 10,275 | 286,262 | 10,275 | |
| Jul 26 2017 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 3,586 | 0 | 19,211 | 15.6 K to 19.2 K (+22.95 %) |
| Jul 21 2017 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Payment of Exercise | F | 27.58 | 1,428 | 39,384 | 15,625 | 17.1 K to 15.6 K (-8.37 %) |
| Jun 26 2017 | SIEN | Sientra, Inc. | OBOYLE KEVIN C | Director | Grant | A | 9.72 | 12,861 | 125,009 | 31,546 | 18.7 K to 31.5 K (+68.83 %) |
| May 30 2017 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 7,832 | 0 | 65,595 | 57.8 K to 65.6 K (+13.56 %) |
| Apr 28 2017 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Option Exercise | J | 17.48 | 30,000 | 524,400 | 0 | |
| Apr 28 2017 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Option Exercise | J | 6.34 | 10,645 | 67,489 | 0 | |
| Apr 28 2017 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Option Exercise | J | 10.21 | 40,871 | 417,293 | 0 | |
| Apr 28 2017 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Option Exercise | J | 5.06 | 1,391 | 7,038 | 0 | |
| Apr 28 2017 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Sell | J | 0.00 | 11,985 | 0 | 0 | 12 K to 0 (-100.00 %) |
| Oct 17 2016 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Payment of Exercise | F | 23.71 | 1,177 | 27,907 | 17,053 | 18.2 K to 17.1 K (-6.46 %) |
| Sep 19 2016 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Option Exercise | M | 6.34 | 7,500 | 47,550 | 10,645 | |
| Sep 19 2016 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Sell | S | 40.08 | 7,500 | 300,612 | 11,985 | 19.5 K to 12 K (-38.49 %) |
| Sep 19 2016 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Buy | M | 6.34 | 7,500 | 47,550 | 19,485 | 12 K to 19.5 K (+62.58 %) |
| Aug 10 2016 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Option Exercise | M | 6.34 | 11,855 | 75,161 | 18,145 | |
| Aug 10 2016 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Option Exercise | M | 5.06 | 5,645 | 28,564 | 1,391 | |
| Aug 10 2016 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Sell | S | 39.00 | 7,500 | 292,500 | 11,985 | 19.5 K to 12 K (-38.49 %) |
| Aug 10 2016 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Sell | S | 37.00 | 10,000 | 370,000 | 19,485 | 29.5 K to 19.5 K (-33.92 %) |
| Aug 10 2016 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Buy | M | 6.34 | 11,855 | 75,161 | 29,485 | 17.6 K to 29.5 K (+67.24 %) |
| Aug 10 2016 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Buy | M | 5.06 | 5,645 | 28,564 | 17,630 | 12 K to 17.6 K (+47.10 %) |
| Jul 21 2016 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | A | 21.24 | 11,765 | 249,889 | 11,765 | |
| Jul 21 2016 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 4,094 | 0 | 18,230 | 14.1 K to 18.2 K (+28.96 %) |
| Jun 27 2016 | SIEN | Sientra, Inc. | OBOYLE KEVIN C | Director | Grant | A | 6.69 | 18,685 | 125,003 | 18,685 | 0 to 18.7 K |
| Jun 23 2016 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Grant | A | 28.23 | 6,199 | 174,998 | 11,985 | 5.8 K to 12 K (+107.14 %) |
| May 31 2016 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 9,965 | 0 | 57,763 | 47.8 K to 57.8 K (+20.85 %) |
| Nov 04 2015 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Buy | P | 6.71 | 4,500 | 30,195 | 47,798 | 43.3 K to 47.8 K (+10.39 %) |
| Oct 15 2015 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Option Exercise | A | 20.62 | 11,018 | 227,191 | 11,018 | |
| Oct 15 2015 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 3,808 | 0 | 14,136 | 10.3 K to 14.1 K (+36.87 %) |
| Oct 05 2015 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Payment of Exercise | F | 20.67 | 423 | 8,743 | 10,328 | 10.8 K to 10.3 K (-3.93 %) |
| Aug 14 2015 | SIEN | Sientra, Inc. | OBOYLE KEVIN C | Director | Option Exercise | A | 25.18 | 7,037 | 177,192 | 16,127 | |
| Aug 14 2015 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Payment of Exercise | F | 23.85 | 493 | 11,758 | 10,751 | 11.2 K to 10.8 K (-4.38 %) |
| Aug 11 2015 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Payment of Exercise | F | 23.78 | 314 | 7,467 | 11,244 | 11.6 K to 11.2 K (-2.72 %) |
| Aug 11 2015 | TRNX | Wright Medical Gro ... | OBOYLE KEVIN C | Director | Payment of Exercise | F | 23.82 | 591 | 14,078 | 11,558 | 12.1 K to 11.6 K (-4.86 %) |
| Aug 06 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Option Exercise | M | 5.06 | 2,500 | 12,650 | 7,036 | |
| Aug 06 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Option Exercise | M | 6.03 | 7,500 | 45,225 | 0 | |
| Aug 06 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Sell | S | 37.02 | 2,500 | 92,545 | 5,786 | 8.3 K to 5.8 K (-30.17 %) |
| Aug 06 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Sell | S | 37.03 | 7,500 | 277,760 | 8,286 | 15.8 K to 8.3 K (-47.51 %) |
| Aug 06 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Buy | M | 5.06 | 2,500 | 12,650 | 15,786 | 13.3 K to 15.8 K (+18.82 %) |
| Aug 06 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Buy | M | 6.03 | 7,500 | 45,225 | 13,286 | 5.8 K to 13.3 K (+129.62 %) |
| Aug 03 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Option Exercise | M | 6.03 | 7,800 | 47,034 | 7,500 | |
| Aug 03 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Sell | S | 35.57 | 1,200 | 42,684 | 5,786 | 7 K to 5.8 K (-17.18 %) |
| Aug 03 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Sell | S | 34.72 | 6,600 | 229,157 | 6,986 | 13.6 K to 7 K (-48.58 %) |
| Aug 03 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Buy | M | 6.03 | 7,800 | 47,034 | 13,586 | 5.8 K to 13.6 K (+134.81 %) |
| Jul 27 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Option Exercise | M | 6.03 | 3,900 | 23,517 | 15,300 | |
| Jul 27 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Sell | S | 33.00 | 3,900 | 128,700 | 5,786 | 9.7 K to 5.8 K (-40.26 %) |
| Jul 27 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Buy | M | 6.03 | 3,900 | 23,517 | 9,686 | 5.8 K to 9.7 K (+67.40 %) |
| Jul 23 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 790 | 0 | 5,786 | 5 K to 5.8 K (+15.81 %) |
| Jun 29 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Option Exercise | M | 6.03 | 800 | 4,824 | 19,200 | |
| Jun 29 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Sell | S | 33.00 | 800 | 26,400 | 4,996 | 5.8 K to 5 K (-13.80 %) |
| Jun 29 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Buy | M | 6.03 | 800 | 4,824 | 5,796 | 5 K to 5.8 K (+16.01 %) |
| Jun 19 2015 | ZLTQ | Zeltiq Aesthetics ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 4,996 | 0 | 4,996 | 0 to 5 K |
| Jun 01 2015 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 7,604 | 0 | 43,298 | 35.7 K to 43.3 K (+21.30 %) |
| Jan 19 2005 | NUVA | NUVASIVE INC | OBOYLE KEVIN C | CFO and Executive V ... | Option Exercise | M | 3.75 | 778 | 2,918 | 25,888 | |
| Jan 19 2005 | NUVA | NUVASIVE INC | OBOYLE KEVIN C | CFO and Executive V ... | Option Exercise | M | 3.75 | 4,222 | 15,833 | 47,112 | |
| Jan 19 2005 | NUVA | NUVASIVE INC | OBOYLE KEVIN C | CFO and Executive V ... | Sell | S | 11.00 | 778 | 8,558 | 43,333 | 44.1 K to 43.3 K (-1.76 %) |
| Jan 19 2005 | NUVA | NUVASIVE INC | OBOYLE KEVIN C | CFO and Executive V ... | Buy | M | 3.75 | 778 | 2,918 | 44,111 | 43.3 K to 44.1 K (+1.80 %) |
| Jan 19 2005 | NUVA | NUVASIVE INC | OBOYLE KEVIN C | CFO and Executive V ... | Sell | S | 11.00 | 4,222 | 46,442 | 43,333 | 47.6 K to 43.3 K (-8.88 %) |
| Jan 19 2005 | NUVA | NUVASIVE INC | OBOYLE KEVIN C | CFO and Executive V ... | Buy | M | 3.75 | 4,222 | 15,833 | 47,555 | 43.3 K to 47.6 K (+9.74 %) |
| Dec 21 2004 | NUVA | NUVASIVE INC | OBOYLE KEVIN C | VP, Finance and CFO | Option Exercise | A | 9.50 | 25,000 | 237,500 | 25,000 | |
| Dec 16 2004 | NUVA | NUVASIVE INC | OBOYLE KEVIN C | VP, Finance and CFO | Option Exercise | M | 3.75 | 12,000 | 45,000 | 51,334 | |
| Dec 16 2004 | NUVA | NUVASIVE INC | OBOYLE KEVIN C | VP, Finance and CFO | Sell | S | 9.49 | 12,000 | 113,920 | 43,333 | 55.3 K to 43.3 K (-21.69 %) |
| Dec 16 2004 | NUVA | NUVASIVE INC | OBOYLE KEVIN C | VP, Finance and CFO | Buy | M | 3.75 | 12,000 | 45,000 | 55,333 | 43.3 K to 55.3 K (+27.69 %) |
| Oct 22 2004 | NUVA | NUVASIVE INC | OBOYLE KEVIN C | VP, Finance and CFO | Option Exercise | A | 9.50 | 45,000 | 427,500 | 45,000 |
Page: 1